Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial-Reference-Cited by-同舟云学术

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

Published:2017-10 Issue:10 Volume:16 Page:781-788
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Logallo Nicola,Novotny Vojtech,Assmus Jörg,Kvistad Christopher E,Alteheld Lars,Rønning Ole Morten,Thommessen Bente,Amthor Karl-Friedrich,Ihle-Hansen Hege,Kurz Martin,Tobro Håkon,Kaur Kamaljit,Stankiewicz Magdalena,Carlsson Maria,Morsund Åse,Idicula Titto,Aamodt Anne Hege,Lund Christian,Næss Halvor,Waje-Andreassen Ulrike,Thomassen Lars

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference25 articles.

1. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials;Lees;Lancet,2010

2. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action;Bhatia;Stroke,2010

3. Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis;Whiteley;Lancet Neurol,2016

4. Therapeutic potential of tenecteplase in the management of acute ischemic stroke;Logallo;CNS Drugs,2015

5. New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA;Benedict;Circulation,1995

Cited by 334 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke;JAMA;2024-09-12

2. Novel metabolic biomarkers for the diagnosis of acute ischemic stroke;Biomarkers in Medicine;2024-09-05

3. Improving thrombolysis efficiency for acute ischaemic stroke;The Lancet Neurology;2024-09

4. Optimizing Acute Ischemic Stroke Outcomes: The Role of Tenecteplase Before Mechanical Thrombectomy;Clinical Therapeutics;2024-09

5. Angioedema Following Tenecteplase for Acute Ischemic Stroke;Stroke;2024-08